Fidelity Investments’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Fidelity Investments’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-683,200	Closed	-$28.2M	–	2845
2015 Q2	$28.2M	Buy	683,200 +214,000	+46%	+$7.67M	﹤0.01%	1591
2015 Q1	$16.5M	Sell	469,200 -48,600	-9%	-$1.64M	﹤0.01%	1804
2014 Q4	$16.6M	Buy	517,800 +95,600	+23%	+$2.76M	﹤0.01%	1813
2014 Q3	$11.8M	Sell	422,200 -89,964	-18%	-$2.74M	﹤0.01%	1942
2014 Q2	$15.5M	Buy	512,164 +152,764	+43%	+$4.22M	﹤0.01%	1907
2014 Q1	$9.95M	Buy	359,400 +349,400	+3,494%	+$9.14M	﹤0.01%	2024
2013 Q4	$255K	Buy	+10,000	New	+$308K	﹤0.01%	2571

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Fidelity Investments's BRLI Position: Q3 2015 in Review

Fidelity Investments sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 683,200 shares — an estimated $28.2M sold.

Fidelity Investments first reported a position in BRLI in Q4 2013 and held it in 7 quarters. The position peaked at $28.2M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Fidelity Investments reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Fidelity Investments sold 683,200 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $28.2M.
Fidelity Investments first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 7 quarters.
Fidelity Investments's BIO-REFERENCE LABS INC-NEW- position peaked at $28.2M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Fidelity Investments's 13F filing for Q3 2015, filed 10 Nov 2015.